These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

72 related articles for article (PubMed ID: 3406049)

  • 1. Adherence to lithium prophylaxis: I. Clinical predictors and patient's reasons for nonadherence.
    Maarbjerg K; Aagaard J; Vestergaard P
    Pharmacopsychiatry; 1988 May; 21(3):121-5. PubMed ID: 3406049
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adherence to lithium prophylaxis: II. Multivariate analysis of clinical, social, and psychosocial predictors of nonadherence.
    Aagaard J; Vestergaard P; Maarbjerg K
    Pharmacopsychiatry; 1988 Jul; 21(4):166-70. PubMed ID: 3205885
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Correlation between drug treatment adherence and lithium treatment attitudes and knowledge by bipolar patients.
    Rosa AR; Marco M; Fachel JM; Kapczinski F; Stein AT; Barros HM
    Prog Neuropsychopharmacol Biol Psychiatry; 2007 Jan; 31(1):217-24. PubMed ID: 16982121
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Predictors of prophylactic response to lithium].
    Rohayem J; Baylé JF; Richa S
    Encephale; 2008 Sep; 34(4):394-9. PubMed ID: 18922242
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Compliance with long-term lithium treatment in major affective disorders.
    Danion JM; Neunreuther C; Krieger-Finance F; Imbs JL; Singer L
    Pharmacopsychiatry; 1987 Sep; 20(5):230-1. PubMed ID: 3671494
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Clinical predictors of long-term outcome of lithium prophylaxis in bipolar disorder].
    Garcia-López A; Ezquiaga E; Nieves P; Rodríguez-Salvanés F
    Actas Esp Psiquiatr; 2001; 29(5):327-32. PubMed ID: 11602090
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prophylaxis of schizoaffective disorder with lithium or carbamazepine: outcome after long-term follow-up.
    Baethge C; Gruschka P; Berghöfer A; Bauer M; Müller-Oerlinghausen B; Bschor T; Smolka MN
    J Affect Disord; 2004 Apr; 79(1-3):43-50. PubMed ID: 15023479
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Factors that affect adherence to bipolar disorder treatments: a stated-preference approach.
    Johnson FR; Ozdemir S; Manjunath R; Hauber AB; Burch SP; Thompson TR
    Med Care; 2007 Jun; 45(6):545-52. PubMed ID: 17515782
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Controlled lithium discontinuation in bipolar patients with good response to long-term lithium prophylaxis.
    Yazici O; Kora K; Polat A; Saylan M
    J Affect Disord; 2004 Jun; 80(2-3):269-71. PubMed ID: 15207941
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Compliance during lithium treatment, intra-erythrocyte lithium variability, and relapse.
    Harvey NS; Kay R
    J Clin Psychopharmacol; 1991 Dec; 11(6):362-7. PubMed ID: 1770155
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Suicidal risk in bipolar I disorder patients and adherence to long-term lithium treatment.
    Gonzalez-Pinto A; Mosquera F; Alonso M; López P; Ramírez F; Vieta E; Baldessarini RJ
    Bipolar Disord; 2006 Oct; 8(5 Pt 2):618-24. PubMed ID: 17042834
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Prospective study of favorable factors in follow-up of drug addicted patients--apropos of 257 patients of the Cassini Center in Paris].
    Goeb JL; Coste J; Bigot T; Ferrand I
    Encephale; 2000; 26(6):11-20. PubMed ID: 11217533
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Factors associated with treatment nonadherence among US bipolar disorder patients.
    Baldessarini RJ; Perry R; Pike J
    Hum Psychopharmacol; 2008 Mar; 23(2):95-105. PubMed ID: 18058849
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Long-term catamnesis on the topic of uses and side effects of lithium prevention of phasic psychoses].
    Koufen H; Consbruch U
    Fortschr Neurol Psychiatr; 1989 Sep; 57(9):374-82. PubMed ID: 2507426
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adherence to treatment regimen in a lithium carbonate clinic.
    Connelly CE; Davenport YB; Nurnberger JI
    Arch Gen Psychiatry; 1982 May; 39(5):585-8. PubMed ID: 6807256
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The longitudinal polymorphism of bipolar I disorders and its theoretical implications.
    Marneros A; Roettig S; Roettig D; Tscharntke A; Brieger P
    J Affect Disord; 2008 Apr; 107(1-3):117-26. PubMed ID: 17884177
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Eight years follow-up of lithium prophylaxis in patients of psychiatric-neurological practice (author's transl)].
    Kurek M; Consbruch U
    Pharmacopsychiatria; 1982 Mar; 15(2):65-9. PubMed ID: 7079292
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Maintenance lithium treatment: side effects and compliance.
    Gitlin MJ; Cochran SD; Jamison KR
    J Clin Psychiatry; 1989 Apr; 50(4):127-31. PubMed ID: 2925600
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Trends in lithium treatment and research during the last decade.
    Schou M
    Pharmacopsychiatria; 1982 Jul; 15(4):128-30. PubMed ID: 7146091
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Continuation versus discontinuation of lithium in recurrent bipolar illness: a naturalistic study.
    Biel MG; Peselow E; Mulcare L; Case BG; Fieve R
    Bipolar Disord; 2007 Aug; 9(5):435-42. PubMed ID: 17680913
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.